Relationship Between Skeletal Muscle Mass and Interventricular Septum Thickness in Apparently Healthy Overweight and Obese Subjects
1 other identifier
observational
120
1 country
1
Brief Summary
The study was aimed at investigating the relationship between skeletal muscle mass and interventricular septum thickness in overweight and obese subjects (BMI≥25)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 7, 2020
CompletedFirst Posted
Study publicly available on registry
February 11, 2020
CompletedFebruary 12, 2020
February 1, 2020
9 months
February 7, 2020
February 10, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
interventricular septum thickness
interventricular septum thickness (mm)
Baseline
skeletal muscle mass
skeletal muscle mass (kg)
Baseline
Secondary Outcomes (12)
Vitamin D
Baseline
Insulin
Baseline
eGFR (estimated glomerular filtration rate)
Baseline
Creatinin
Baseline
Total cholesterol
Baseline
- +7 more secondary outcomes
Interventions
Observational
Eligibility Criteria
Patients who came to the Outpatient Clinic of Nutrition at the National Institute of Gastroenterology "S. de Bellis," Research Hospital, Castellana Grotte, Italy.
You may qualify if:
- Overweight or obesity (BMI\> 25 Kg/m2)
You may not qualify if:
- Any kind of drug
- Hypertension
- Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
- Chronic inflammatory diseases
- Renal failure
- Liver failure
- Angina pectoris
- Myocardial infarction and heart failure
- Genetic heart diseases
- Thrombocytopenias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Gastroenterology IRCCS S. de Bellis
Castellana Grotte, Bari, 70132, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
February 7, 2020
First Posted
February 11, 2020
Study Start
January 1, 2019
Primary Completion
October 1, 2019
Study Completion
November 1, 2019
Last Updated
February 12, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share